|
34 Companies |
|
37 Products |
|
37 Products |
|
35 Mechanisms of Action |
|
2 Trials |
|
396 News |
|
| «12345678» |
- Trial primary completion date: CAMMPS: Comprehensive vs. Assisted Management of Mood and Pain Symptoms (clinicaltrials.gov) - May 13, 2016
P3, N=300, Enrolling by invitation, Sponsor: VA Office of Research and Development
Trial primary completion date: Mar 2017 --> Jun 2017
- triamcinolone acetonide / Generic mfg.
Enrollment closed, Trial primary completion date: Using Saline for Myofascial Pain Syndromes (USAMPS) (clinicaltrials.gov) - May 13, 2016
P4, N=102, Active, not recruiting, Sponsor: The University of Texas Health Science Center, Houston
Trial primary completion date: Mar 2017 --> Jun 2017 Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2016 --> Dec 2016
- Enrollment change, Trial termination: Neurostimulation in Temporomandibular Disorders (TMD) Patients (clinicaltrials.gov) - Apr 26, 2016
P=N/A, N=5, Terminated, Sponsor: University of North Carolina, Chapel Hill
Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2016 --> Dec 2016 N=20 --> 5 | Enrolling by invitation --> Terminated; recruiting difficulties
- Trial completion, Enrollment change: Peer Mentorship: An Intervention To Promote Effective Pain Self-Management In Adolescents (clinicaltrials.gov) - Mar 9, 2016
P=N/A, N=27, Completed, Sponsor: University of California, Los Angeles
N=20 --> 5 | Enrolling by invitation --> Terminated; recruiting difficulties Recruiting --> Completed | N=56 --> 27
- Trial primary completion date: Mindfulness Interventions and Chronic Widespread Pain in Adolescents (clinicaltrials.gov) - Mar 8, 2016
P=N/A, N=24, Recruiting, Sponsor: Yale University
Recruiting --> Completed | N=56 --> 27 Trial primary completion date: Jul 2016 --> Nov 2016
- Enrollment change, Trial withdrawal, Trial primary completion date: Cytokine and Growth Factor Changes and Correlation With Clinical Outcomes Following Acupuncture for TMD (clinicaltrials.gov) - Feb 23, 2016
P=N/A, N=0, Withdrawn, Sponsor: University of North Carolina, Chapel Hill
Trial primary completion date: Jul 2016 --> Nov 2016 N=36 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Dec 2016 --> Feb 2016
- Trial completion, Surgery: An Evaluation of Psychological Parameters That May Influence the Outcome Following Arthroscopy and Arthroplasty for Temporomandibular Joint Surgery (clinicaltrials.gov) - Feb 17, 2016
P=N/A, N=105, Completed, Sponsor: Emory University
N=36 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Dec 2016 --> Feb 2016 Active, not recruiting --> Completed
- Trial completion: Tai Chi and Aerobic Exercise for Fibromyalgia (FMEx) (clinicaltrials.gov) - Feb 10, 2016
P=N/A, N=224, Completed, Sponsor: Tufts Medical Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Radial Shock Wave and Acupuncture for Myofascial Pain (clinicaltrials.gov) - Feb 4, 2016
P=N/A, N=68, Completed, Sponsor: Shin Kong Wu Ho-Su Memorial Hospital
Active, not recruiting --> Completed Recruiting --> Completed
- | Trial completion, Trial primary completion date: Cognitive Behavioral Insomnia Therapy for Individuals With Fibromyalgia (clinicaltrials.gov) - Jan 30, 2016
P2/3, N=111, Completed, Sponsor: Duke University
Recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Oct 2016 --> Feb 2011
- Trial primary completion date: The Pathogenesis of Idiopathic Dry Eyes (clinicaltrials.gov) - Jan 27, 2016
P=N/A, N=100, Active, not recruiting, Sponsor: University of Michigan
Active, not recruiting --> Completed | Trial primary completion date: Oct 2016 --> Feb 2011 Trial primary completion date: Dec 2015 --> Dec 2017
- Enrollment change: Rheumatic Diseases and Computer Use (clinicaltrials.gov) - Jan 25, 2016
P=N/A, N=359, Completed, Sponsor: University of Pittsburgh
Trial primary completion date: Dec 2015 --> Dec 2017 N=1200 --> 359
- Trial completion, Trial primary completion date: STIMALGI: Repetitive Transcranial Magnetic Stimulation in Fibromyalgia (clinicaltrials.gov) - Jan 19, 2016
P=N/A, N=42, Completed, Sponsor: University Hospital, Grenoble
N=1200 --> 359 Recruiting --> Completed | Trial primary completion date: Feb 2016 --> Sep 2015
- Trial primary completion date: Acute Effects of Exercise in Women With Fibromyalgia (FM) (clinicaltrials.gov) - Jan 17, 2016
P=N/A, N=60, Recruiting, Sponsor: G
Recruiting --> Completed | Trial primary completion date: Feb 2016 --> Sep 2015 Trial primary completion date: Dec 2015 --> Dec 2016
- Enrollment change, Trial termination, Trial primary completion date: rTMS for the Treatment of Chronic Pain in GW1 Veterans (clinicaltrials.gov) - Dec 12, 2015
P3, N=16, Terminated, Sponsor: VA Office of Research and Development
Trial primary completion date: Dec 2015 --> Dec 2016 N=206 --> 16 | Active, not recruiting --> Terminated | Trial primary completion date: Sep 2016 --> Jun 2015; Did not meet recruitment goals
- Trial completion, Enrollment change: Neurotropin Treatment of Fibromyalgia (clinicaltrials.gov) - Dec 10, 2015
P2, N=55, Completed, Sponsor: National Institute of Nursing Research (NINR)
N=206 --> 16 | Active, not recruiting --> Terminated | Trial primary completion date: Sep 2016 --> Jun 2015; Did not meet recruitment goals Recruiting --> Completed | N=78 --> 55
- Trial completion: Pain and Stress Management for Fibromyalgia (clinicaltrials.gov) - Dec 9, 2015
P2, N=230, Completed, Sponsor: Wayne State University
Recruiting --> Completed | N=78 --> 55 Active, not recruiting --> Completed
- calcitonin/benzyl alcohol/phenyl ethyl alcohol/aqueous buffer / Generic mfg.
Enrollment change, Trial withdrawal, Trial primary completion date: CALFI: Calcitonin in the Treatment of Fibromyalgia (clinicaltrials.gov) - Dec 7, 2015
P4, N=0, Withdrawn, Sponsor: Unidad de Investigacion en Enfermedades Cronico-Degenerativas
Active, not recruiting --> Completed N=40 --> 0 | Enrolling by invitation --> Withdrawn | Trial primary completion date: Jun 2009 --> Feb 2009
- Trial completion, HEOR: Effects of Hydrotherapy on Physical Function and Quality of Life of Women With Fibromyalgia (clinicaltrials.gov) - Dec 4, 2015
P=N/A, N=19, Completed, Sponsor: Mariana Arias Avila
N=40 --> 0 | Enrolling by invitation --> Withdrawn | Trial primary completion date: Jun 2009 --> Feb 2009 Active, not recruiting --> Completed
- | Trial completion, Enrollment change: Online Acceptance-based Behavioural Treatment for Fibromyalgia (clinicaltrials.gov) - Dec 4, 2015
P3, N=67, Completed, Sponsor: University of Manitoba
Active, not recruiting --> Completed Active, not recruiting --> Completed | N=100 --> 67
- Trial completion: The CARRA Registry (clinicaltrials.gov) - Nov 17, 2015
P=N/A, N=9587, Completed, Sponsor: Duke University
Active, not recruiting --> Completed | N=100 --> 67 Enrolling by invitation --> Completed
- Trial primary completion date: Cognitive Behavioral Insomnia Therapy for Individuals With Fibromyalgia (clinicaltrials.gov) - Nov 15, 2015
P2/3, N=111, Active, not recruiting, Sponsor: Duke University
Enrolling by invitation --> Completed Trial primary completion date: Oct 2015 --> Oct 2016
- Trial completion, Trial primary completion date: Tai Chi Mind-Body Therapy for Fibromyalgia (clinicaltrials.gov) - Nov 10, 2015
P=N/A, N=66, Completed, Sponsor: Tufts Medical Center
Trial primary completion date: Oct 2015 --> Oct 2016 Active, not recruiting --> Completed | Trial primary completion date: May 2015 --> Jun 2011
- Enrollment closed: Tai Chi and Aerobic Exercise for Fibromyalgia (FMEx) (clinicaltrials.gov) - Nov 9, 2015
P=N/A, N=216, Active, not recruiting, Sponsor: Tufts Medical Center
Active, not recruiting --> Completed | Trial primary completion date: May 2015 --> Jun 2011 Recruiting --> Active, not recruiting
- ||||||| Tonmya (cyclobenzaprine SL) / Tonix
Trial completion, Enrollment change: 12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients (clinicaltrials.gov) - Oct 26, 2015
P3, N=158, Completed, Sponsor: Tonix Pharmaceuticals, Inc.
Recruiting --> Active, not recruiting Enrolling by invitation --> Completed | N=120 --> 158
- Trial initiation date, Trial primary completion date: FIBROPATHIC: Osteopathic Medicine in Fibromyalgia Syndrome (clinicaltrials.gov) - Oct 22, 2015
P=N/A, N=150, Not yet recruiting, Sponsor: Assistance Publique - H
Enrolling by invitation --> Completed | N=120 --> 158 Initiation date: Jan 2015 --> Nov 2015 | Trial primary completion date: Jan 2017 --> Nov 2017
- Emsam (selegiline transdermal) / Viatris
Trial completion, Enrollment change, Trial primary completion date: Clinical Research Study to Evaluate Selegiline in the Treatment of Borderline Personality Disorder (clinicaltrials.gov) - Oct 8, 2015
P3, N=30, Completed, Sponsor: Mood and Anxiety Research, Inc
Initiation date: Jan 2015 --> Nov 2015 | Trial primary completion date: Jan 2017 --> Nov 2017 Recruiting --> Completed | N=38 --> 30 | Trial primary completion date: Dec 2013 --> Mar 2015
- Trial completion, Enrollment change: Brain Rhythms in Fibromyalgia: A Magnetoencephalography (MEG) Study (clinicaltrials.gov) - Oct 7, 2015
P=N/A, N=40, Completed, Sponsor: New York University School of Medicine
Recruiting --> Completed | N=38 --> 30 | Trial primary completion date: Dec 2013 --> Mar 2015 Recruiting --> Completed | N=80 --> 40
- Trial primary completion date: Mindfulness Interventions and Chronic Widespread Pain in Adolescents (clinicaltrials.gov) - Sep 24, 2015
P=N/A, N=24, Recruiting, Sponsor: Yale University
Recruiting --> Completed | N=80 --> 40 Trial primary completion date: Jul 2015 --> Jul 2016
- Trial completion, Enrollment change, Trial primary completion date: Complementary and Alternative Medicine (CAM) for Fibromyalgia (clinicaltrials.gov) - Sep 24, 2015
P=N/A, N=431, Completed, Sponsor: Oregon Health and Science University
Trial primary completion date: Jul 2015 --> Jul 2016 Recruiting --> Completed | N=48 --> 431 | Trial primary completion date: Dec 2015 --> Jul 2015
- Savella (milnacipran) / AbbVie, Pierre Fabre
Enrollment change, Trial withdrawal, HEOR: The Effect of Milnacipran on Fatigue and Quality of Life in Lupus Patients (clinicaltrials.gov) - Sep 18, 2015
P4, N=0, Withdrawn, Sponsor: Loma Linda University
Recruiting --> Completed | N=48 --> 431 | Trial primary completion date: Dec 2015 --> Jul 2015 N=50 --> 0 | Recruiting --> Withdrawn
- Trial completion: TheraFast: Effects of Fasting on Self Efficacy (clinicaltrials.gov) - Sep 4, 2015
P=N/A, N=120, Completed, Sponsor: Universit
N=50 --> 0 | Recruiting --> Withdrawn Recruiting --> Completed
- Trial completion, Enrollment change: The Effectiveness of Operant Learning Versus Energy Conservation Activity Pacing Treatments in Fibromyalgia (clinicaltrials.gov) - Sep 3, 2015
P=N/A, N=69, Completed, Sponsor: Lawson Health Research Institute
Recruiting --> Completed Not yet recruiting --> Completed | N=120 --> 69
- Trial primary completion date: Pain Sensitivity of Subjects With Fibromyalgia Before and After Repetitive Transcranial Magnetic Stimulation Treatment (clinicaltrials.gov) - Aug 21, 2015
P=N/A, N=72, Recruiting, Sponsor: Centre Hospitalier Esquirol
Not yet recruiting --> Completed | N=120 --> 69 Trial primary completion date: Aug 2015 --> Aug 2016
- Trial primary completion date: Efficiency of Repetitive Transcranial Magnetic Stimulation (rTMS) Sessions After a Successful 3 Week-treatment in Fibromyalgia (clinicaltrials.gov) - Aug 21, 2015
P=N/A, N=78, Recruiting, Sponsor: Centre Hospitalier Esquirol
Trial primary completion date: Aug 2015 --> Aug 2016 Trial primary completion date: Feb 2015 --> Aug 2016
- ||||||| duloxetine / Generic mfg.
Trial completion: Double Blind Trial of Duloxetine in Chronic Fatigue Syndrome (clinicaltrials.gov) - Aug 21, 2015
P2/3, N=60, Completed, Sponsor: University of Cincinnati
Trial primary completion date: Feb 2015 --> Aug 2016 Active, not recruiting --> Completed
- Enrollment status: The Effect of Tai Chi in Treating Fibromyalgia (clinicaltrials.gov) - Aug 18, 2015
P=N/A, N=120, Enrolling by invitation, Sponsor: Chengdu PLA General Hospital
Active, not recruiting --> Completed Recruiting --> Enrolling by invitation
- Lodonal (naltrexone low dose oral) / Immune Therap, Statera BioPharma
Enrollment change: Low Dose Naltrexone for the Treatment of Juvenile Primary Fibromyalgia Syndrome (clinicaltrials.gov) - Aug 17, 2015
P=N/A, N=0, Withdrawn, Sponsor: Stanford University
Recruiting --> Enrolling by invitation N=40 --> 0
- Trial termination, Trial primary completion date: PERRFECT-301: Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301 (clinicaltrials.gov) - Aug 14, 2015
P=N/A, N=236, Terminated, Sponsor: Cerephex Corporation
Interim analysis results missed primary endpoint, intended signal not delivered in Tx arm, sham results as expected. No safety issues.
- Enrollment closed, Trial primary completion date: Treatment of Temporomandibular Dysfunction With Hypertonic Dextrose Injection (clinicaltrials.gov) - Aug 12, 2015
P2/3, N=40, Active, not recruiting, Sponsor: Chisel Peak Medical Clinic
No safety issues. Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2015 --> Mar 2016
- Enrollment change, Trial termination: Whole Body Hyperthermia Registry Study (clinicaltrials.gov) - Aug 5, 2015
P=N/A, N=2, Terminated, Sponsor: University of Arizona
Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2015 --> Mar 2016 N=60 --> 2 | Recruiting --> Terminated; Investigator transferred to the University of Wisconsin - Madison
- Enrollment change, Trial withdrawal: Fibro and WBH: Whole Body Hyperthermia (WBH) as a Rapid Treatment for Fibromyalgia (clinicaltrials.gov) - Jul 29, 2015
P=N/A, N=0, Withdrawn, Sponsor: Charles (Chuck) Raison
N=60 --> 2 | Recruiting --> Terminated; Investigator transferred to the University of Wisconsin - Madison N=15 --> 0 | Recruiting --> Withdrawn
- Trial primary completion date: TheraFast: Effects of Fasting on Self Efficacy (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=120, Recruiting, Sponsor: Universit
N=15 --> 0 | Recruiting --> Withdrawn Trial primary completion date: Mar 2015 --> Jul 2015
- Trial primary completion date: Acute Effects of Exercise in Women With Fibromyalgia (FM) (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=60, Recruiting, Sponsor: G
Trial primary completion date: Mar 2015 --> Jul 2015 Trial primary completion date: Apr 2015 --> Dec 2015
- Trial primary completion date: The New Serial Treatment of Temporomandibular Disorders (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=4, Recruiting, Sponsor: Sun Yat-sen University
Trial primary completion date: Apr 2015 --> Dec 2015 Trial primary completion date: Dec 2014 --> Dec 2018
- Enrollment open, Trial primary completion date: Effect of the Method Pilates in Women With Temporomandibular Disorders (clinicaltrials.gov) - Jun 1, 2015
P=N/A, N=40, Recruiting, Sponsor: Federal University of Rio Grande do Sul
Trial primary completion date: Dec 2014 --> Dec 2018 Not yet recruiting --> Recruiting | Trial primary completion date: Sep 2015 --> Sep 2016
- Trial completion, Enrollment change, Trial primary completion date: Nutrition and Coping Education for Symptom and Weight Management for Fibromyalgia (clinicaltrials.gov) - May 28, 2015
P2, N=45, Completed, Sponsor: University of Utah
Not yet recruiting --> Recruiting | Trial primary completion date: Sep 2015 --> Sep 2016 Active, not recruiting --> Completed | N=80 --> 45 | Trial primary completion date: Aug 2012 --> Sep 2011
- Enrollment closed, Trial primary completion date: Immediate Effect of Ultrasound Therapy on Bilateral Masseter Myalgia: Randomized Single Blinded Investigational Trial (clinicaltrials.gov) - May 14, 2015
P=N/A, N=28, Active, not recruiting, Sponsor: State University of New York at Buffalo
Active, not recruiting --> Completed | N=80 --> 45 | Trial primary completion date: Aug 2012 --> Sep 2011 Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2015 --> May 2015
- ampreloxetine (TD-9855) / Theravance Biopharma
Phase classification: Levosimendan in Acute Heart Failure Following Acute Myocardial Infarction. (clinicaltrials.gov) - May 13, 2015
P1, N=6, Completed, Sponsor: Theravance Biopharma R & D, Inc.
Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2015 --> May 2015 Phase classification: P4 --> P1
- Trial completion: Effects of Thai Massage on EMG (clinicaltrials.gov) - May 6, 2015
P=N/A, N=50, Completed, Sponsor: Mae Fah Luang University Hospital
Phase classification: P4 --> P1 Recruiting --> Completed